21 September 2018 in Gynecological Endocrinology
Betatrophin is defined as a new marker in glucose homeostasis and lipid metabolism. We aimed to investigate the role of serum betatrophin in full-blown polycystic ovary syndrome (PCOS) patients and 47-aged healthy women, 51 full-blown PCOS patients were included in this cross-sectional study. Betatrophin concentrations were significantly lower in PCOS group and displayed a positive correlation only with serum tryglyceride in control group (p < .05). A cutoff level (464.5 ng/L) was determined for betatrophin according to Receiver Operating Characteristic curve. Using this value, 64.7% of PCOS patients were classified as below the cutoff and in this group betatrophin was found to correlate negatively with fasting glucose, fasting insulin, and homeostasis model assessment of insulin resistance (p = .038, p = .020, and p = .014, respectively), and positively with total testosterone (p = .041). In the rest of PCOS cases (35.3%) who had betatrophin higher than cutoff, positive correlation was found with low-density lipoprotein cholesterol (p = .009). In conclusion, betatrophin levels are reduced in full-blown PCOS patients who had worse metabolic phenotype.
1 August 2018 in Archives of Endocrinology and Metabolism
Keywords Thyroid nodules; malignancy; PET-CT, SUVmax; Hounsfield Unit
1 January 2016 in Endocrinology Research and Practice
Insulinoma is the most common type of islet cell tumor of the pancreas and its incidence is estimated at four per one million persons per year. Although fasting hypoglycemia is the typical presentation, cases with postprandial hypoglycemia have rarely been reported. A 48-year-old woman was admitted to our department for evaluation of hypoglycemia. Laboratory data suggested a state of postprandial endogenous hyperinsulinemic hypoglycemia. Abdominal computed tomography revealed a mass lesion measuring 20 mm at the distal pancreas. A decision was made to perform an arterial calcium-stimulated venous sampling for excluding nesidioblastosis coexisting with a pancreatic incidental mass. After that the patient was referred to surgery. Pathological examination revealed a low-grade well-differentiated neuroendocrine tumor with regional lymph node metastasis. Herein, we report a case of malignant insulinoma presenting with postprandial hypoglycemia and discuss the differential diagnosis and possible mechanisms of postprandial hypoglycemia in insulinoma cases.
30 September 2019 in Cukurova Medical Journal
Purpose: Fasting during Ramadan is a religious obligation for Muslims. Extended fasting can create undesirable acute complications of diabetes such as hypoglycemia or hyperglycemia. In this study, we aimed to evaluate the impact of fasting on glucose regulation in diabetic patients who fast during Ramadan.Materials and Methods: Patients were informed about the possible side effects of fasting for them and those who stated that they will be fasting during Ramadan were called one month after Ramadan. In this retrospective cohort study by telephone interview, the number of fasting days, daily measurements of glucose, the number of acute complications if existed and whether the patients have changed their treatments were asked.Results: Forty six patients were included in this study. Mean age was 54.3±9.5 yr. The average fasting day was 25.24±2.4. They were categorized according to the risk stratifications. The number of hypoglycemic events was not higher than detected six months prior to the Ramadan. Most of the patients had hyperglycemia rather than hypoglycemia. All of the patients who had hypo-or hyperglycemia did not interrupt their fasting and did not change their medications. Conclusion: Patients who fasted during Ramadan have a tendency both hypoglycemia and hyperglycemia. To improve glycemic regulation and keep these patients in a safe and acceptable glucose range, Pre-Ramadan education is necessary.
8 May 2018 in Endocrine Abstracts
Objectives: Detection rate of thyroid nodules is increasing with use of new imaging modalities, like 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). To avoid unnecessary operations, differentiating between benign and malignant 18F-FDG PET/CT-positive thyroid nodules is essential. Many authorities recommend fine needle aspiration biopsy (FNAB) for exclusion of malignancy in thyroid nodules. Although FNAB is a simple, easily performed procedure, less invasive diagnostic approaches are required. Malignant thyroid nodules tend to have higher maximum standardized uptake values (SUVmax) but there is no clear information about the utility of Hounsfield Unit (HU) values for the prediction of malignancy. This study evaluated the HU values beside SUVmax for detecting malignancy risk of PET/CT-positive thyroid nodules. Methods: We retrospectively studied 98 patients who had FNAB for thyroid nodules detected on PET/CT within the period; January 2011 to December 2015. The FNABs and surgical pathological results were recorded. On non-contrast CT scans taken during PET imaging, the HU of the nodules were calculated besides SUV max values of the nodules. Results: The mean age of the study population was 57.6±13.8 years, and 75 (76.5%) of the patients were women. The most common primary malignancy detected in these patients was breast cancer. If more than one nodule was detected on a PET/CT scan, FNAB was performed on the nodule that had the higher SUVmax. FNABs revealed benign results in 32 patients (32.7%), malignant in 18 (18.4%), non-diagnostic in 20 (20.4%), indeterminate in 28 (28.5%). 24 patients underwent thyroidectomy due to their inconvenient general health conditions. When the FNAB and postoperative pathological results of nodules evaluated together, 38 of them were considered as benign and 25 of them were malignant. Only 24.5% of the cases were subjected to thyroidectomy, the malignancy rate was 25.5% in our cohort. Mean SUVmax was significantly higher (P< 0.001) in malignant versus benign nodules. Area under curve (AUC) was 0.824 for SUVmax; the cut-off value was over 5.55 (P<0.001), with 80% sensitivity, 84.5% specificity. But mean HU values were not significantly different (P=0.73). Conclusions: We defined a SUVmax cut-off value of 5.5 for malignant potential of thyroid nodules detected on PET/CT. However; we did not find any merit in using HU values for discriminating between malignant and benign nodules.
13 May 2016 in Endocrine Abstracts
Introduction: Radiotherapy to the head and neck area is the standard therapy used for the treatment of nasopharyngeal carcinoma. Hypopituitarism is a well-known late complication of cranial radiotherapy. Although very rarely, it may be observed following radiotherapy to the head and neck area, as well. Case report: A 53-year-old man was referred to our endocrinology department for hyponatremia and low free thyroxine (T4) with normal thyroid- stimulating hormone levels. His medical history was remarkable only for the nasopharyngeal carcinoma that had been treated with radiation and chemotherapy seven years before admission. He had been hospitalized many times due to hyponatremia in other hospitals within the last six months. He had been discharged every time after the correction of his serum sodium levels. On physical examination, he was pale and lethargic. Blood pressure was 85/50 mmHg, heart rate was 74 bpm. His random cortisol level was 3 μg/dl. Besides cortisol, his testosterone, luteinizing hormone and insulin-like growth factor-1 levels were also below normal limits. Magnetic resonance imaging (MRI) exhibited normal findings in his pituitary. Based on these results, the patient was diagnosed to have panhypopituitarism due to the radiotherapy that he once had for his nasopharyngeal carcinoma. Hormonal substitution therapy with IV glucocorticoids and levoT4 was started sequentially. His serum sodium level gradually rose up to normal limits. He no longer required intravenous sodium replacement. Conclusion: Hyponatremia is often seen in patients with adrenal insufficiency but the diagnosis of hypopituitarism in hyponatremic patients is often overlooked and these patients had been admitted to the hospitals many times before the underlying hypopituitarism was diagnosed. Radiotherapy to the head and neck area may cause hypopituitarism and thus hyponatremia in long term follow-up. Taking careful medical history plays the pivotal role in making the correct diagnostic approaches.